TegoScience Inc. (KOSDAQ: A191420)
Health Care · Biotechnology · KR
₩7,550.00
-11.18% today · -54.8% 1Y
TegoScience Inc. (KOSDAQ: A191420) operates in the Biotechnology industry within the Health Care sector. The company is valued at $43.62M.
Over the last twelve months the share price has lost 54.8%, trading between 5.23K and 19.37K.
Tweenvest scores TegoScience Inc. across four factors: quality 52/100, value 61/100. Its strongest factor is value.
A191420 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $43.62M
- Revenue (TTM)
- $3.99M
- P/E
- —
- EPS
- -1,611.49
- Dividend yield
- —
- Beta (5Y)
- 0.64
- 52-week high
- ₩19,370.00
- 52-week low
- ₩5,230.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.01M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $262.90 | -1.09% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.34 | -0.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.09 | -0.46% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $547.29 | -1.01% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $814.79 | -2.25% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $149.66 | -5.77% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.